r.a, page-3

Thanks for your thoughts Carly.

I feel any share price positive news must address the plans for R.A, and not avoid the topic. It's scary when announcements suddenly change tack expecting readers not to notice. I actually am unhappy I did not follow my gut when i noticed that omission and just hit the sell button. Others did - and we had a full days warning before the Novo announcement.
Of course any news that other Pharmas (there were apparently numerous according to the reports) are still in discussion would have a strongly positive impact on the Share Price.

And this is what management now urgently need (SP to get back up). Whilst $10M is a good buffer it will clearly disappear if RA re-Formulation is needed or Lupus trials are planned. There will be no more Cap Raisings with a S.P at 8c - massive dilution, not enough $, and no more underwriters left, at least not on this planet....